Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
about
IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinomaMED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingA noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasisCD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cellsGemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDFUp-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cellsEGFR Signaling in Liver DiseasesIs there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?Mouse models of liver cancer: Progress and recommendationsEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistanceEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaMurine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brainGenotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitorsTackling Cancer Stem Cells via Inhibition of EMT Transcription FactorsAsbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathwaysNuclear factor-κB-dependent epithelial to mesenchymal transition induced by HIF-1α activation in pancreatic cancer cells under hypoxic conditionsEvidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data.Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion.Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrenceAnti-angiogenic therapy induces integrin-linked kinase 1 up-regulation in a mouse model of glioblastomaEpithelial-mesenchymal transitions and hepatocarcinogenesis.Molecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers.Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulatorsPancreatic cancer stem cells and EMT in drug resistance and metastasis.Rapamycin enhances cetuximab cytotoxicity by inhibiting mTOR-mediated drug resistance in mesenchymal hepatoma cells.Tumour cells expressing single VEGF isoforms display distinct growth, survival and migration characteristicsUnderstanding resistance to EGFR inhibitors-impact on future treatment strategiesmiR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in micePredictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors.Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1A systems view of epithelial-mesenchymal transition signaling states.N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell linesThe role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressivenessMicroRNA-221 mediates the effects of PDGF-BB on migration, proliferation, and the epithelial-mesenchymal transition in pancreatic cancer cells.Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.Sarcomatous transformation of EGFR and TP53 mutation-positive metastatic adenocarcinoma of the lungs, masquerading as a primary pleomorphic sarcoma of the proximal femur.Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis
P2860
Q21261901-CFD89DDA-C0DB-4E37-9D6B-65C5CFAFA08BQ24304423-E76EC57D-A70D-4465-95BC-51A0AEBE18EFQ24307454-3CBD39FE-AE92-4ADF-9492-AA79F17F63A0Q24600745-85199606-19DF-438B-9D94-8B091D1649D7Q24609040-25EE8B33-70F7-411B-803F-A34C50C2ECC1Q24651034-55D64757-39D6-4C7B-9DDD-837D4383AA35Q26771265-F14CC4F2-F7B6-4CAC-AE74-C573BDCB8658Q26798882-FBC736D2-298E-45AA-A3C0-ECF81956B699Q26799788-1A27B9F0-E819-4E06-AB19-4D71825865CAQ26824386-00EC331B-6B51-401F-BF5E-50A2D20F33E9Q26849546-D8DCFA02-0D2D-41FC-B140-BBA5ADFB72D5Q27437644-9DE03EBB-D192-438B-88CE-50F6799B52F3Q27851633-A3EF5B98-00FC-4451-A19A-EDA18EED2F14Q28079863-D0C0F9AF-9B9D-459B-8317-2AC7D1CBB1EBQ28393611-8A26856F-FAEE-4FBC-B9F6-C83CFBD241F8Q28476694-AE95A744-3599-49F2-B7C6-6340CBD8F52EQ30498197-FB12FB96-EFB5-4C55-BC15-B28CDCF9CE09Q30934284-13B3D499-28DF-44BA-A5FB-7F76D7205DB5Q33411986-A16A649C-9A0F-4BD8-9CFA-71D2B3D02FBCQ33556420-2847FF86-0D58-454B-A5EC-4274D480C287Q33741854-CD41036A-378A-4D66-9BF5-65E4536CFDF5Q33755466-92E3E8BC-85C9-46B6-B465-2CAAC13045C8Q33770326-63ECC60B-BDE2-475C-A1EF-DDDE43B831ECQ33852611-8B06F174-FAE3-416C-AA82-B26D517FF5E8Q33886120-6EA7C9DE-CD07-41DB-810A-7E5E217E61ACQ33990018-7DEE1B10-44E8-4AB1-A73D-0146ED22AB47Q34041280-0342491C-1DCC-46D5-9E99-8AA1AFB5B79CQ34088424-B299E93F-F467-4C62-A4D0-B9E3F561F7A9Q34146018-780062CE-8842-41BE-A865-1030285CCDECQ34181598-D49C3F4A-60F9-4E21-977E-2E5046FFA799Q34208986-9B27AF50-B999-4F29-A6AD-F64141A98A75Q34409807-D5BD7F37-D0BD-4890-A7FF-F4484C048F64Q34430583-078C5046-7BD9-4E3F-A8CD-F7E80131CB75Q34579646-1BF25174-A3BA-420D-B1C3-E867FA3B20C9Q34631703-099DCFA8-253C-4D68-BD7D-15B757F1E6BDQ34885299-106D8563-858C-4DD6-BC1B-313A23C65199Q34963831-25280FB4-DC1D-45FE-BE82-F01EF7C7551BQ35001415-6E563275-16AD-4E4B-9674-02FEAB2C5428Q35632411-B90C07CE-A979-4F0D-80D2-73684A54697CQ36129640-95E25569-BC6F-4007-B2C5-3DE415A96765
P2860
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@en
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@nl
type
label
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@en
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@nl
prefLabel
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@en
Epithelial-to-mesenchymal tran ...... ition in human hepatoma cells.
@nl
P2093
P1433
P1476
Epithelial-to-mesenchymal tran ...... bition in human hepatoma cells
@en
P2093
Andrew X Zhu
Jon D Dorfman
Jonathan M Goodwin
Kenneth K Tanabe
Michael Lanuti
Tsutomu Fujii
P304
P356
10.1158/0008-5472.CAN-07-2460
P407
P577
2008-04-01T00:00:00Z